Crystal-Induced Arthritis Clinical Trial
Official title:
Features of Microcrystalline Polyarthritis Treated by Biologics and Evolution - FUMBLE Study
The study will involve adult patient who had received any biologic agent for microcrystalline
disease in western France (Tours, Le Mans, Orléans, Angers, Rennes, Poitiers et Brest)
between 01/01/2010 and 31/12/2018.
Investigators will answer retrospectively a questionnaire that covers patient and disease
data, biologic agent use, efficacy and adverse events.
This is a retrospective multicentric study of all patients treated by biologic for
microcrystalline disease in France in western France (Tours, Le Mans, Nantes, La Roche sur
Yon, Orléans, Angers, Rennes, Poitiers et Brest) between 01/01/2010 and 31/12/2018.
The investigators will collect all clinical (diagnosis of gout CCPD or hydroxyapatitis,
tender and swollen joint count), biological (blood results: ESR, CRP, uric acid, synovial
analysis), radiological data (X-rays performed and their description) .
;